In his doctoral dissertation completed at the University of Jyväskylä, Finland, Tero Sievänen demonstrates that the cancer risk of Lynch syndrome carriers can be assessed based on circulating microRNA ...

MicroRNAs are small non-coding RNA molecules that orchestrate gene expression by guiding degradation or translational repression of target messenger RNAs. In cancer, dynamic changes in microRNA ...

Add Yahoo as a preferred source to see more of our stories on Google. RNA is more than just a transitional state between DNA and protein. Christoph Burgstedt/Science Photo Library via Getty Images ...

Researchers at Purdue University have developed a new type of cancer therapy that uses a modified microRNA, miR-34a, to block cancer cell division. In preclinical tests in mice, treatment using the ...

MicroRNAs (miRNAs) are short non-coding RNAs that regulate gene expression post-transcriptionally by pairing with messenger RNAs and promoting their repression or degradation. Biogenesis begins with ...

A new cancer therapy developed by Purdue University researchers attacks tumors by tricking cancer cells into absorbing a snippet of RNA that naturally blocks cell division. As reported in Oncogene, ...

(Nanowerk News) Cancer is one of the most devastating diseases in the world. In 2023, more than 1.9 million new cancer cases and 609,820 deaths are projected to occur in the United States alone. As ...

Prostate cancer remains one of the most common cancers among men, yet current screening tools often fail to distinguish between harmless and aggressive forms of the disease. This review highlights how ...

miRNA offers a fresh perspective for cancer diagnosis. It is widely present in body fluids, and numerous studies have shown that its expression is correlated with the occurrence and progression of ...

SiSaf has agreed to collaborate with the University of Leipzig to develop Bio-Courier targeted micro interfering RNAs (miRNA) for the treatment of cancer, with an initial focus on pancreatic cancer.

A new University of Cincinnati Cancer Center study has identified a particular strand of microRNA as a promising new target for overcoming breast cancer treatment resistance and improving outcomes.

The Nobel Prize in Medicine was awarded on Monday to two US scientists for discovering microRNA, a previously unknown type of genetic switch which is hoped can pave the way for new medical ...